It was reported that on (b)(6) 2017, a 21mm trifecta gt valve was successfully implanted in a patient.On an unknown date, the patient was hospitalized and perivalvular leakage/regurgitation of the 21mm trifecta gt valve was discovered.It was noted that there was no calcification of the valve.The decision was made to perform a valve-in-valve procedure using an unknown device.
|
An event of paravalular leak and replacement of the valve with a valve-in-valve was reported.Information from the field indicated that there was no calcification on the valve.A more comprehensive assessment, including histopathological examination of the valve tissue could not be performed as the device remains implanted and was not returned for analysis.The cause of the reported event could not be conclusively determined.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
|